COMMITTEES
CORPORATE & BUSINESS COMMITTEE
All members are automatically part of the Corporate & Business Committee, where they will have a voice in shaping federal regulations; establish close relationships with federal regulators and their advisors; network and collaborate among members; receive multidiscipline intelligence reports; and be informed by the work of the other committees.
This committee is chaired by Bruce Linton, Chairman of Canopy Growth and co-chaired by William Huber, Counsel at Nemphos Braue LLC.
This committee is chaired by Bruce Linton, Chairman of Canopy Growth and co-chaired by William Huber, Counsel at Nemphos Braue LLC.
PUBLIC POLICY COMMITTEE
The Public Policy Committee members will be primarily responsible for interacting with legislators and regulators and formulating policy recommendations for CFCR. The Public Policy professionals from committee-level members are eligible to participate on this committee.
This committee is chaired by Charlie Black, Chair of Prime Policy, and Kristine Blackwood, Kristine Blackwood, LLC. Gretchen Gailey, Founder Panoptic Strategies, as Co-Chair
This committee is chaired by Charlie Black, Chair of Prime Policy, and Kristine Blackwood, Kristine Blackwood, LLC. Gretchen Gailey, Founder Panoptic Strategies, as Co-Chair
SCIENCE & REGULATORY AFFAIRS COMMITTEE
The Scientific & Regulatory Affairs Committee will develop new tools and more technologically advanced scientific frameworks that meet FDA safety and efficacy requirements and, in addition, assist the industry and the FDA in achieving the regulatory clarity that is required for cannabis products to go mainstream.
This committee is chaired by William Garvin, co-head of the Cannabis Practice Group at Buchanan Ingersoll & Rooney
This committee is chaired by William Garvin, co-head of the Cannabis Practice Group at Buchanan Ingersoll & Rooney
DEI & ACCESS TO CAPITAL COMMITTEE
The DEI & Access to Capital Committee will provide the cannabis industry guidance on diversity and social equity programs that have been adopted by Fortune 1000 companies, and champion the adoption of regulations that assist those hurt by prior drug laws. In addition, it will seek to educate the business community about the disparate impact of prior drug laws on minorities and the poor. Human Resources and diversity professionals from committee level members are eligible to participate on this committee.
This committee is chaired by Christine De La Rosa, CEO and Co-Founder at The People's Ecosystem.
This committee is chaired by Christine De La Rosa, CEO and Co-Founder at The People's Ecosystem.
Join Us
